Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
429.30    0.30 (0.07%)
Bid:
428.60
Ask:
428.90
Spread: 0.30 (0.07%)
Market Cap: £10.80b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Purchase of Vector Disease Acquisition LLC

13 Nov 2017 07:00

RNS Number : 2414W
Rentokil Initial PLC
13 November 2017
 

13 November 2017

 

ACQUISITION OF LEADING VECTOR CONTROL COMPANY IN NORTH AMERICA

Up-weighted M&A spend guidance for H2 2017 to £100m+

Rentokil Initial plc (FTSE: RTO, "the Company") today announces that is has acquired Vector Disease Acquisition, LLC ("VDA"), North America's largest provider of mosquito control services.

For many vector-borne diseases such as Zika Virus, West Nile Virus, Yellow Fever, Malaria and Dengue Fever, vector control services are the most effective way to protect public health.

 

VDA provides a full range of vector control services, including weekly monitoring of mosquito levels, species identification and disease testing (using its in-house laboratory) and control of both adult and larval mosquitoes from the ground and using aircraft. In line with this acquisition, the Company is establishing a new global centre of excellence for mosquito control, which will be based in North America.

 

VDA also provides lake management services, a new route-based service line for Rentokil North America. Invasive aquatic plants destroy fish and wildlife, and clog pipes used for drinking water, hydroelectric and irrigation supplies. Services include chemical treatments, mechanical vegetation removal, aeration and fountain management. The Lake Management division, which is predominately a contract portfolio business, is also the largest of its type in North America.

 

Headquartered in Little Rock, Arkansas, VDA operates from 52 offices in 32 U.S. states. Annualised revenues for the 12 months prior to acquisition were c. $47m (£36m).

Commenting on the acquisition, Andy Ransom, CEO of Rentokil Initial, said:

"The growing threat to public health from mosquitoes makes vector control an important and growing part of the overall pest control market. Factors such as climate change and increased travel are leading to more vector-borne disease outbreaks than ever before.

"We are now positioned strongly in two attractive markets that are characterised by good growth, high technical skill level and strong regulatory requirements, attributes that play well to Rentokil Initial's traditional strengths and expertise. This is another important step towards our ambition to create a business in North America with revenues of c. $1.5bn and margins of c. 18% by the end of 2020.

"Given the increasing demand for mosquito control in many parts of the world and the unrivalled expertise in VDA, this is also a significant acquisition for our global pest control business.

"Our M&A pipeline remains very strong and therefore we now expect spend to be £100m+ in H2 2017."

For further information please contact:

Rentokil Initial plc

Investors

Katharine Rycroft

07811 270 734

Media

Malcolm Padley

07788 978 199

 

Notes to editors:

Rentokil Initial

· Rentokil Initial plc is one of the largest business services companies in the world, operating in 70 countries and employing 35,500 colleagues. The Company offers route-based services, primarily in Pest Control and Hygiene, through teams of local experts. Rentokil is the world's largest commercial pest control company.

 

· For more information, visit www.rentokil-initial.com.

Vector Disease Acquisition, LLC ("VDA")

Mosquito Control Services

· The main mosquito control operations operate under a legal entity called Vector Disease Control International, LLC. 

· Demand for mosquito control is driven by public health needs or a combination of public health and nuisance management and is highly technically focused. VDA provides a full range of mosquito control services. 90% of revenues are contracted.

 

· VDA serves primarily governmental customers (cities, counties and mosquito abatement districts plus the Federal Centers for Disease Control (CDC)) but there are also some industrial customers.

 

· The US vector control market for municipalities and government is estimated at $400m p.a.

 

· The business has a high-experienced management team and employees 80 FTE and ~300 seasonal employees. VDA's aerial division has 14 aircraft operating out of 4 airports.

 

Lake Management Services

· The main lake management operations operate under a legal entity called Solitude Lake Management, LLC.

 

· Lake Management provides services primarily on the east coast of the USA. Customers are municipal, state and federal governments, homeowner associations, lake associations, golf courses and corporate entities.

 

· Revenues are predominately contracted with services including aeration and fountain management, controlling invasive aquatic vegetation and algae in lakes and ponds.

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQOKKDNFBDDDDD
Date   Source Headline
21st May 20267:00 amRNSAppointment of CEO, North America
8th May 202610:30 amRNSHolding(s) in Company
7th May 20264:40 pmRNSResult of AGM
23rd Apr 20264:25 pmRNSFinal Dividend – Pence Sterling Amount Payable
23rd Apr 20262:30 pmRNSIssuance of $500 million 4.625% Notes due 2031
21st Apr 202610:30 amRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ1 Trading Update
15th Apr 20267:00 amRNSDirectorate Change
30th Mar 202610:30 amRNSHolding(s) in Company
26th Mar 20263:46 pmRNSDirector/PDMR Shareholding
25th Mar 202610:50 amRNSAnnual Financial Report
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
16th Mar 202610:32 amRNSHolding(s) in Company
16th Mar 202610:32 amRNSHolding(s) in Company
12th Mar 202610:30 amRNSHolding(s) in Company
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:28 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
10th Mar 20264:26 pmRNSDirector/PDMR Shareholding
9th Mar 202611:15 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSPreliminary Results
5th Mar 20267:00 amRNSChair Succession Planning Update
23rd Feb 202610:30 amRNSHolding(s) in Company
19th Feb 20262:50 pmRNSDirector Declaration
12th Feb 20265:30 pmRNSNotice of Early Redemption
20th Jan 202610:25 amRNSHolding(s) in Company
19th Jan 202610:30 amRNSHolding(s) in Company
16th Jan 20263:00 pmRNSHolding(s) in Company
14th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 202610:30 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSDirectorate change
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
19th Dec 202511:00 amRNSDirector/PDMR Shareholding
5th Dec 202510:30 amRNSHolding(s) in Company
5th Dec 202510:30 amRNSHolding(s) in Company
26th Nov 20254:25 pmRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
28th Oct 202510:45 amRNSHolding(s) in Company
27th Oct 202510:30 amRNSHolding(s) in Company
23rd Oct 202511:45 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 Trading Update
21st Oct 202510:00 amRNSHolding(s) in Company
14th Oct 202510:00 amRNSHolding(s) in Company
1st Oct 202510:30 amRNSBlock listing Interim Review
30th Sep 202510:30 amRNSCompletion of France Workwear business sale
25th Sep 20254:15 pmRNSDirector/PDMR Shareholding
24th Sep 20256:00 pmRNSDirector Declaration
26th Aug 202512:30 pmRNSInterim Dividend – Pence Sterling Amount Payable
7th Aug 202511:10 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.